{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:42:40Z","timestamp":1789879360957,"version":"4.0.1"},"reference-count":42,"publisher":"Microbiology Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"abstract":"<jats:p>To understand the prospects for human papillomavirus (HPV) mass vaccination in the setting of a developing country, we studied the co-occurrence of seropositivity to multiple high-risk (hr) HPV types among HIV-positive and HIV-negative Ugandan women. Our seroepidemiological study was conducted among 2053 women attending antenatal clinics. Sera were analysed for antibodies to eight hrHPV types of the \u03b1-7 (18\/45) and \u03b1-9 (16\/31\/33\/35\/52\/58) species of HPV by using a multiplex serology assay. Our results show that seropositivity for greater than one hrHPV type was as common (18\u200a%) as for a single type (18\u200a%). HIV-positive women had higher HPV16, HPV18 and HPV45 seroprevalences than HIV-negative women. In multivariate logistic regression analysis, age (&gt;30 years) and level of education (secondary school and above) reduced the risk, whereas parity (&gt;5) and HIV-positivity increased the risk for multiple hrHPV seropositivity. However, in stepwise logistic regression analyses, HIV-status remained the only independent, stand-alone risk factor [odds ratio (OR) 1.7, 95\u200a% confidence interval (CI) 1.0\u20132.8). On the other hand, the risk of HPV16 or HPV18 seropositive women, as compared to HPV16 or HPV18 seronegative women, for being seropositive to other hrHPV types was not significantly different when they were grouped by HIV-status (OR<jats:sub>HPV16\/HIV+<\/jats:sub> 12, 95\u200a% CI 4.5\u201332 versus OR<jats:sub>HPV16\/HIV\u2212<\/jats:sub> 22, 95\u200a% CI 15\u201331 and OR<jats:sub>HPV18\/HIV+<\/jats:sub> 58, 95\u200a% CI 14\u2013242 versus OR<jats:sub>HPV18\/HIV\u2212<\/jats:sub> 45, 95\u200a% CI 31\u201365). In conclusion, seropositivity to HPV16, HPV18 and to non-vaccine hrHPV types is common in Ugandan women, suggesting that there is little natural cross-protective immunity between the types. HIV-positivity was an independent, stand-alone, albeit moderate risk factor for multiple hrHPV seropositivity. HPV mass vaccination may be the most appropriate method in the fight against cervical cancer in the Ugandan population.<\/jats:p>","DOI":"10.1099\/vir.0.035923-0","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:28:03Z","timestamp":1313022483000},"page":"2776-2783","source":"Crossref","is-referenced-by-count":10,"title":["Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women"],"prefix":"10.1099","volume":"92","author":[{"given":"P. B.","family":"Namujju","sequence":"first","affiliation":[{"name":"School of Health Sciences, University of Tampere, Tampere, Finland"},{"name":"Uganda Virus Research Institute, Entebbe, Uganda"},{"name":"National Institute for Health and Welfare, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Waterboer","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Banura","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Muwonge","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Mbidde","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Byaruhanga","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, San Raphael of St Francis Hospital Nsambya, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Muwanga","sequence":"additional","affiliation":[{"name":"Entebbe Hospital, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-M.","family":"Surcel","sequence":"additional","affiliation":[{"name":"National Institute for Health and Welfare, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pawlita","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1086\/517428"},{"key":"r2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23762"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1086\/526792"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-5-7"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20817"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1086\/315498"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000253361.63578.14"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0349"},{"key":"r11","article-title":"Combating cross-generational sex in Uganda","author":"Clifton","year":"2009"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e3282f75ea1"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.6.1394"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2796"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1086\/342972"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0191"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24539"},{"key":"r18","first-page":"159","article-title":"An assessment of the readiness for introduction of the HPV vaccine in Uganda","volume":"12","author":"Katahoire","year":"2008","journal-title":"Afr J Reprod Health"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200009000-00001"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02052.x"},{"key":"r21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1099\/0022-1317-80-2-391","article-title":"Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study","volume":"80","author":"Kjellberg","year":"1999","journal-title":"J Gen Virol"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25675"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.356"},{"key":"r24","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg171"},{"key":"r25","doi-asserted-by":"publisher","DOI":"10.1086\/421467"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000148081.38331.92"},{"key":"r27","doi-asserted-by":"publisher","DOI":"10.3109\/00365540903582426"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-170"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-85"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"r31","doi-asserted-by":"publisher","DOI":"10.3109\/00365540903501608"},{"key":"r32","volume-title":"Cancer Incidence in Five Continents","volume":"vol. VIII","author":"Parkin","year":"2002"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2678"},{"key":"r34","doi-asserted-by":"publisher","DOI":"10.1086\/315026"},{"key":"r35","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.034009"},{"key":"r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014705"},{"key":"r37","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.007823-0"},{"key":"r38","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0129"},{"key":"r39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601034"},{"key":"r40","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.052381"},{"key":"r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2005.11.008"},{"key":"r42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04956-4"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.035923-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T03:18:07Z","timestamp":1603423087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.035923-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.035923-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,1]]}}}